Skip to main content

Table 1 Patient characteristics at renal biopsy

From: Association of explanatory histological findings and urinary protein and serum creatinine levels at renal biopsy in lupus nephritis: a cross-sectional study

n = 119(%)
Age, years45(±16)
Sex, female, n (%)94(79)
Observation period, days2958(±2584)
SLEDAI-2 K score16(±6)53.8
ISN/RPS classification   
Class III, n (%)20(17)
Class III + V, n (%)2(10)
Class IV, n (%)84(71)
Class IV + V, n (%)7(8)0.8
Class V, n (%)15(13)
Max dose of PSL, mg/day37(±15)5.0
Immunosuppressive therapy for remission induction  4.2
PSL alone, n (%)46(39) 
Cyclophosphamide, n (%)31(26)
Tacrolimus or cyclosporine, n (%)22(19)
Mycophenolate mofetil, n (%)13(11)
Others, n (%)2(2)
Serum creatinine, mg/dl0.87(±0.51)
eGFR, ml/min/m277.3(±31.0)
Urinary protein, g/gCr3.00(±2.78)
Hematuria (scale > 2+), n (%)52(44)2.5
Active urinary sediment, n (%)77(65)4.2
  1. Data are presented as the mean and standard deviation in brackets. SLEDAI-2 K Systemic Lupus Erythematosus Disease Activity Index 2000; ISN/RPS International Society of Nephrology/Renal Pathology Society; PSL Prednisolone; eGFR Estimated glomerular filtration rate